Targeted Histone Deacetylase Inhibition for Cancer Therapy

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|4|2|205-218

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.4, Iss.2, 2004-03, pp. : 205-218

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Multi-Targeted Histone Deacetylase Inhibitors in Cancer Therapy

By  

Current Medicinal Chemistry, Vol. 19, Iss. 4, 2012-02 ,pp. : 475-487

Bentham Science Publishers

Access to resources Recommend Favorite

Histone Deacetylase Inhibitors: An Attractive Strategy for Cancer Therapy

By  

Current Medicinal Chemistry, Vol. 20, Iss. 14, 2013-05 ,pp. : 1858-1886

Bentham Science Publishers

Access to resources Recommend Favorite

Histone Deacetylase Inhibitors in Psoriasis Therapy

By  

Current Drug Targets. Inflammation & Allergy, Vol. 3, Iss. 2, 2004-06 ,pp. : 213-219

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting histone deacetylase in thyroid cancer

By Russo Diego   Durante Cosimo   Bulotta Stefania   Puppin Cinzia   Puxeddu Efisio   Filetti Sebastiano   Damante Giuseppe  

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 2, 2013-02 ,pp. : 179-193

Informa Healthcare

Access to resources Recommend Favorite

The Synergistic Effects of DNA-Targeted Chemotherapeutics and Histone Deacetylase Inhibitors As Therapeutic Strategies for Cancer Treatment

By  

Current Medicinal Chemistry, Vol. 19, Iss. 25, 2012-09 ,pp. : 4218-4238

Bentham Science Publishers

Access to resources Recommend Favorite